Is EXACT Sciences Stock a Good Investment?
EXACT Sciences Investment Advice | EXAS |
- Examine EXACT Sciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research EXACT Sciences' leadership team and their track record. Good management can help EXACT Sciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact EXACT Sciences' business and its evolving consumer preferences.
- Compare EXACT Sciences' performance and market position to its competitors. Analyze how EXACT Sciences is positioned in terms of product offerings, innovation, and market share.
- Check if EXACT Sciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about EXACT Sciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in EXACT Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if EXACT Sciences is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine EXACT Sciences Stock
Researching EXACT Sciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are held by institutions such as insurance companies. The book value of EXACT Sciences was currently reported as 17.35. The company recorded a loss per share of 1.16. EXACT Sciences had not issued any dividends in recent years.
To determine if EXACT Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding EXACT Sciences' research are outlined below:
| EXACT Sciences generated a negative expected return over the last 90 days | |
| EXACT Sciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 2.5 B. Net Loss for the year was (204.15 M) with profit before overhead, payroll, taxes, and interest of 1.51 B. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Geode Capital Management LLC Buys 7,873 Shares of Exact Sciences Co. |
EXACT Sciences Quarterly Liabilities And Stockholders Equity |
|
EXACT Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in EXACT Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EXACT Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact EXACT Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises EXACT Sciences' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2011-05-03 | 2011-03-31 | -0.09 | -0.08 | 0.01 | 11 | ||
2010-10-27 | 2010-09-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2010-05-06 | 2010-03-31 | -0.05 | -0.06 | -0.01 | 20 | ||
2014-02-20 | 2013-12-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2013-10-29 | 2013-09-30 | -0.18 | -0.16 | 0.02 | 11 | ||
2006-07-24 | 2006-06-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2004-10-25 | 2004-09-30 | -0.19 | -0.17 | 0.02 | 10 | ||
2013-05-01 | 2013-03-31 | -0.2 | -0.17 | 0.03 | 15 |
Know EXACT Sciences' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as EXACT Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EXACT Sciences backward and forwards among themselves. EXACT Sciences' institutional investor refers to the entity that pools money to purchase EXACT Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | T. Rowe Price Associates, Inc. | 2024-09-30 | 3.3 M | Geode Capital Management, Llc | 2024-09-30 | 3.1 M | Champlain Investment Partners, Llc | 2024-09-30 | 2.5 M | Holocene Advisors, Lp | 2024-09-30 | 1.9 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.8 M | Macquarie Group Ltd | 2024-09-30 | 1.5 M | Cam Group Holding A/s | 2024-09-30 | 1.5 M | Bellevue Group Ag | 2024-09-30 | 1.4 M | Zevenbergen Capital Investments Llc | 2024-09-30 | 1.4 M | Fmr Inc | 2024-09-30 | 21.6 M | Vanguard Group Inc | 2024-09-30 | 17.8 M |
EXACT Sciences' market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 10.62 B.EXACT Sciences' profitablity analysis
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.Determining EXACT Sciences' profitability involves analyzing its financial statements and using various financial metrics to determine if EXACT Sciences is a good buy. For example, gross profit margin measures EXACT Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of EXACT Sciences' profitability and make more informed investment decisions.
EXACT Sciences' Earnings Breakdown by Geography
Please note, the imprecision that can be found in EXACT Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EXACT Sciences. Check EXACT Sciences' Beneish M Score to see the likelihood of EXACT Sciences' management manipulating its earnings.
Evaluate EXACT Sciences' management efficiency
EXACT Sciences has return on total asset (ROA) of (0.0216) % which means that it has lost $0.0216 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0676) %, meaning that it created substantial loss on money invested by shareholders. EXACT Sciences' management efficiency ratios could be used to measure how well EXACT Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Evaluating the management effectiveness of EXACT Sciences allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The EXACT Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta 1.272 |
Basic technical analysis of EXACT Stock
As of the 19th of December, EXACT Sciences owns the Variance of 14.51, market risk adjusted performance of 0.5371, and Standard Deviation of 3.81. EXACT Sciences technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm EXACT Sciences risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if EXACT Sciences is priced correctly, providing market reflects its prevailing price of 56.84 per share. Given that EXACT Sciences has information ratio of (0.04), we urge you to verify EXACT Sciences's latest market performance to make sure the company can sustain itself in the future.EXACT Sciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EXACT Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
EXACT Sciences' Outstanding Corporate Bonds
EXACT Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EXACT Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EXACT bonds can be classified according to their maturity, which is the date when EXACT Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| US30063PAB13 Corp BondUS30063PAB13 | View | |
| US30063PAC95 Corp BondUS30063PAC95 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand EXACT Sciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing EXACT Sciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.5371 | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (2,839) | |||
| Standard Deviation | 3.81 | |||
| Variance | 14.51 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.5271 | |||
| Maximum Drawdown | 27.38 | |||
| Value At Risk | (3.14) | |||
| Potential Upside | 4.21 | |||
| Skewness | (3.13) | |||
| Kurtosis | 21.96 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.5371 | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (2,839) | |||
| Standard Deviation | 3.81 | |||
| Variance | 14.51 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.5271 | |||
| Maximum Drawdown | 27.38 | |||
| Value At Risk | (3.14) | |||
| Potential Upside | 4.21 | |||
| Skewness | (3.13) | |||
| Kurtosis | 21.96 |
Consider EXACT Sciences' intraday indicators
EXACT Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EXACT Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0854 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 59.5 | |||
| Day Typical Price | 58.61 | |||
| Market Facilitation Index | 5.31 | |||
| Price Action Indicator | (2.65) | |||
| Relative Strength Index | 50.26 |
EXACT Sciences Corporate Filings
F4 | 13th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 5th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 7th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
EXACT Stock media impact
Far too much social signal, news, headlines, and media speculation about EXACT Sciences that are available to investors today. That information is available publicly through EXACT media outlets and privately through word of mouth or via EXACT internal channels. However, regardless of the origin, that massive amount of EXACT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of EXACT Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of EXACT Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to EXACT Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive EXACT Sciences alpha.
EXACT Sciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards EXACT Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
EXACT Sciences Corporate Management
| James Herriott | General VP | Profile | |
| Jeffrey CFA | Chief Officer | Profile | |
| Ana Hooker | Chief Officer | Profile | |
| Aaron Bloomer | Executive Finance | Profile | |
| Vic Parker | Head Sales | Profile | |
| Sarah Condella | Executive Resources | Profile |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.